Twenty years on: the impact of fragments on drug discovery
Daniel A. ErlansonCarmot Therapeutics, Inc. 409 Illinois Street, San Francisco, California 94158, USAStephen W. FesikDepartment of Biochemistry, Vanderbilt University School of Medicine, 2215 Garland Avenue, 607 Light Hall, Nashville, Tennessee 37232-0146, USARoderick E. HubbardVernalis Research, Granta Park, Abington, Cambridge CB21 6GB, UKWolfgang JahnkeNovartis Institutes for Biomedical Research, Novartis Campus, CH-4002 Basel, SwitzerlandHarren Jhoti
2016en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references